Given that induction of more qualified CD8<sup>+</sup> T<sub>M</sub> cells is one of the ultimate goals of vaccination, our findings identify additional targets critical to TGF-β-induced T cell memory, which may greatly impact future vaccine development for the treatment of cancer and infectious diseases. Here, CD8A is linked to cancer.